CurrentRheuma
Get Weekly

Topic · page 3 of 17

Osteoporosis & bone health

Postmenopausal, male and glucocorticoid-induced osteoporosis, fracture risk assessment and bone density, fragility fractures and their secondary prevention, anti-resorptive and anabolic drugs, treatment sequence and drug holidays

Briefs 81–120 of 659 placed here, newest publication first

Briefs in Osteoporosis & bone health

Newest publication first

  1. Osteoporos Int

    Revised Swedish FRAX models and the establishment of age-dependent intervention thresholds

    Cohort study

  2. Osteoporos Int

    Parathyroid hormone and alkaline phosphatase are associated with fracture risk in non-dialysis-dependent chronic kidney disease

    Cohort study

  3. Osteoporos Int

    Who receives DXA in VHA direct care vs. community care? Insights into bone health care for veterans

    Cohort study

  4. Arthritis Rheumatol

    Biologic and Targeted Synthetic Disease‐Modifying Antirheumatic Drugs Do Not Arrest Bone Loss in Patients With Rheumatoid Arthritis: A Long‐Term Multicenter Observational Study

    Cohort study

  5. Osteoporos Int

    Development and external validation of prediction models for major osteoporotic fracture and hip fracture in people with intellectual disability

    Diagnostic or prognostic study

  6. Osteoporos Int

    Impact of a national reimbursement add-on policy on refracture risk and secondary fracture prevention after hip fracture in Japan: a population-based interrupted time series analysis

    Cohort study

  7. Osteoporos Int

    The systemic inflammation response index is independently associated with incident fracture risk in older women

    Cohort study

  8. Osteoporos Int

    High prevalence of sarcopenia, osteoporosis and osteosarcopenia in patients with chronic kidney disease compared with healthy controls

    Cross-sectional study

  9. Osteoporos Int

    Romosozumab versus teriparatide for risk of dementia in individuals with osteoporosis: a target trial emulation study

    Cohort study

  10. Osteoporos Int

    Increased osteoporosis burden and comparative antiresorptive effectiveness in inflammatory bowel disease: a real-world cohort study

    Cohort study

  11. Osteoporos Int

    Vertebral fractures and muscle function in glucocorticoid-treated individuals with Duchenne muscular dystrophy: a cohort study

    Cohort study

  12. Osteoporos Int

    High-potency statins are associated with reduced osteoporosis but increased fracture risk in CKD patients: a multi-center retrospective study

    Cohort study

  13. Osteoporos Int

    Romosozumab super-responders in clinical practice: insights from a large Italian multicenter cohort of women with severe postmenopausal osteoporosis

    Cohort study

  14. Osteoporos Int

    Calcium isotope ratio (δ44/42Ca) reflects kidney function and calcium excretion but not bone mineral density or bone turnover: a cross-sectional study

    Cross-sectional study

  15. Osteoporos Int

    Romosozumab versus teriparatide and risk of all-cause mortality in patients with osteoporosis: a real-world propensity score-matched cohort study

    Cohort study

  16. Osteoporos Int

    Diagnostic performance of lumbar computed tomography Hounsfield unit thresholds for osteoporosis and osteopenia: a systematic review and meta-analysis

    Meta-analysis

  17. Osteoporos Int

    Adjusting fracture probability according to duration of diabetes: the Manitoba BMD Registry

    Cohort study

  18. Osteoporos Int

    Association of frailty trajectories with osteoporosis and hip fracture in an older female population

    Cohort study

  19. Osteoporos Int

    Mental disorders and osteoporosis treatment in patients with hip fracture—a Danish population-based cohort study

    Cohort study

  20. Arthritis Res Ther

    Inflammation-related composite indices and their association with osteoporosis and fragility fractures in rheumatoid arthritis

    Cross-sectional study

  21. Osteoporos Int

    Baseline serum PINP is associated with early lumbar spine bone mineral density gains during twice-weekly teriparatide treatment: the OASIS cohort study

    Cohort study

  22. Osteoporos Int

    Effects of health education on treatment adherence, dietary supplement use, and disease health knowledge among people with osteoporosis: a meta-analysis

    Meta-analysis

  23. Osteoporos Int

    Hip bone density is associated with concomitant distal ulna fracture in the setting of distal radius fracture

    Cross-sectional study

  24. Osteoporos Int

    Clinical impact of acute symptomatic vertebral fractures in the United States: A patient survey and chart review

    Cross-sectional study

  25. Osteoporos Int

    Phase 3 study comparing the efficacy and safety of proposed biosimilar RGB-14-P with denosumab in postmenopausal women with osteoporosis: results from the transition (switch) phase

    Randomized controlled trial

  26. Osteoporos Int

    Management of bone health in cancer survivorship: a systematic review of clinical guidelines

    Meta-analysis

  27. Osteoporos Int

    Demographic determinants of REMS-derived BMD and fragility score

    Cross-sectional study

  28. Osteoporos Int

    Association of healthy sleep pattern with the risk of falls and fractures among individuals with cardiovascular disease: a UK Biobank study

    Cohort study

  29. Osteoporos Int

    Does osteosarcopenia synergistically increase risk for incident falls and fractures? A systematic review and meta-analysis

    Meta-analysis

  30. Osteoporos Int

    A new age of osteoanabolic therapy? A real-world, two-centre study comparing effects of romosozumab, teriparatide, and antiresorptive therapies for osteoporosis

    Cohort study

  31. Osteoporos Int

    Impact of splenectomy on fracture risk via the bone-immune axis: A nationwide Korean cohort study

    Cohort study

  32. Lupus Sci Med

    Risk factor of osteoporosis in systemic lupus erythematosus patients: a cross-sectional study in a tertiary hospital in Indonesia

    Cross-sectional study

  33. Osteoporos Int

    The association between GLP-1 receptor agonists and fractures: a nationwide Danish nested case-control study

    Case-control study

  34. Osteoporos Int

    Association of physical activity with fracture: a prospective cohort study of 387,307 Chinese participants

    Cohort study

  35. Osteoporos Int

    Association of orthogeriatric co-management with the occurrence of secondary fragility fractures in patients with an initial hip fracture

    Cohort study

  36. Osteoporos Int

    Predictive value of BMD for hip and other fractures: a meta-analysis to update FRAX

    Meta-analysis

  37. Osteoporos Int

    Comparing home-based and institutional rehabilitation for community-dwelling hip fracture patients: a matched cohort study

    Cohort study

  38. Osteoporos Int

    Secondary fracture risk after hip fracture in older patients: an updated sex-specific systematic review and meta analysis with GRADE and PAF assessment

    Meta-analysis

  39. Osteoporos Int

    Romosozumab is effective in patients with variants in LRP5, LRP6, or WNT1

    Cohort study

  40. Osteoporos Int

    Clinical implementation of AI for vertebral fracture detection in CT aligned with fracture liaison services: high prevalence of undiagnosed vertebral fractures

    Cohort study

All 659 Briefs in ExploreShowing Briefs 81–120 of 659, newest first